Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR–MASH score
出版年份 2023 全文链接
标题
Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR–MASH score
作者
关键词
-
出版物
LIVER INTERNATIONAL
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-10-31
DOI
10.1111/liv.15766
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Rational Combination Therapy for NASH: Insights from Clinical Trials and Error
- (2023) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Head-to-head comparison of MR elastography-based liver stiffness, fat Fraction, and T1 relaxation time in identifying At-Risk NASH
- (2023) Jiahui Li et al. HEPATOLOGY
- Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes
- (2023) Grazia Pennisi et al. HEPATOLOGY
- A multi-society Delphi consensus statement on new fatty liver disease nomenclature
- (2023) Mary E. Rinella et al. HEPATOLOGY
- An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography
- (2023) Jia-xu Liang et al. JOURNAL OF HEPATOLOGY
- American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
- (2022) Kenneth Cusi et al. Endocrine Practice
- Development and validation of a model to predict incident chronic liver disease in the general population: The CLivD score
- (2022) Fredrik Åberg et al. JOURNAL OF HEPATOLOGY
- Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis
- (2022) Giulia Angelini et al. GUT
- Head to head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD
- (2022) Beom Kyung Kim et al. JOURNAL OF HEPATOLOGY
- Changes in abdominal adipose tissue depots assessed by MRI correlate with hepatic histologic improvement in non-alcoholic steatohepatitis
- (2022) Wei Shen et al. JOURNAL OF HEPATOLOGY
- Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis
- (2021) Andrea Dennis et al. Frontiers in Endocrinology
- Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease
- (2021) Nobuharu Tamaki et al. GUT
- Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis
- (2021) Ferenc Emil Mózes et al. GUT
- Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort
- (2021) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Muscle fat content is strongly associated with NASH: a longitudinal study in patients with morbid obesity
- (2021) Maxime Nachit et al. JOURNAL OF HEPATOLOGY
- Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy‐proven nonalcoholic fatty liver disease subjects
- (2021) Javier Ampuero et al. LIVER INTERNATIONAL
- Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
- (2021) Fasiha Kanwal et al. GASTROENTEROLOGY
- MRE plus FIB‐4 (MEFIB) versus FAST in detection of candidates for pharmacological treatment of NASH‐related fibrosis
- (2021) Nobuharu Tamaki et al. HEPATOLOGY
- EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update
- (2021) Annalisa Berzigotti et al. JOURNAL OF HEPATOLOGY
- Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population
- (2021) Isabel Graupera et al. Clinical Gastroenterology and Hepatology
- Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis
- (2021) Anneli Andersson et al. Clinical Gastroenterology and Hepatology
- MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis
- (2021) Mazen Noureddin et al. JOURNAL OF HEPATOLOGY
- Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
- (2021) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease
- (2021) David Martí-Aguado et al. RADIOLOGY
- FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
- (2020) Philip N Newsome et al. Lancet Gastroenterology & Hepatology
- Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials
- (2020) Beth A. Davison et al. JOURNAL OF HEPATOLOGY
- A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study
- (2020) Stephen A Harrison et al. Lancet Gastroenterology & Hepatology
- Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
- (2020) Tracey G Simon et al. GUT
- MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis
- (2020) Jinho Jung et al. GUT
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Alessandro Furlan et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population
- (2018) Fredrik Åberg et al. HEPATOLOGY
- Pharmacotherapy for NASH: Current and emerging
- (2018) Monica A. Konerman et al. JOURNAL OF HEPATOLOGY
- Range of Normal Liver stiffness and Predictors of Suspected Advanced Fibrosis in Apparently Healthy Individuals: A Pooled Analysis of 16,082 Participants
- (2018) Fateh Bazerbachi et al. Clinical Gastroenterology and Hepatology
- The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity
- (2018) Javier Ampuero et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
- (2017) Thomas Karlas et al. JOURNAL OF HEPATOLOGY
- Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography
- (2016) Kento Imajo et al. GASTROENTEROLOGY
- Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
- (2016) Rocío Gallego-Durán et al. Scientific Reports
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started